1. What's on the Horizon for Soft Tissue Sarcoma?

3. Sarcoma Incidence and Mortality

4. Sarcoma Classification

5. Survival Data From Sarcoma Trials EORTC 62012

6. GeDDiS Trial

7. PICASSO 3 Trial

8. Key Takeaways From Chemotherapy Trials in Soft Tissue Sarcomas

9. Targeting PDGF/PDGFR in Sarcoma

10. Pazopanib

11. Pazopanib PALETTE Study

12. Olaratumab (IMC-3G3)*

13. Doxorubicin ± Olaratumab for Treatment of Advanced STS

14. Liposarcomas

15. Leiomyosarcomas

16. Trabectedin

18. Trabectedin vs Dacarbazine for Advanced Liposarcoma or Leiomyosarcoma

19. Eribulin Mesylate

20. Eribulin vs Dacarbazine for Advanced Liposarcoma or Leiomyosarcoma

21. Eribulin vs Dacarbazine for Advanced Liposarcoma or Leiomyosarcoma

22. Palbociclib*

23. Summary and Conclusions

24. Abbreviations

25. Abbreviations (cont)